Von Hippel-Lindau Disease: the Clinical Manifestations and Genetic Analysis Results of Two Cases from a Single Family

Overview

Journal Balkan J Med Genet

Publisher Sciendo

Specialty Genetics

Date 2016 Oct 28

PMID 27785399

Authors

S Kinyas

S A Ozal

H Guclu

V Gurlu

H Esgin

H Gurkan

Affiliations

Soon will be listed here.

Abstract

von Hippel-Lindau (VHL) disease is an autosomal dominant inherited multi systemic cancer syndrome that is classically associated with neoplasms in multiple organs, and caused by mutations in the gene on chromosome 3p25-p26. Retinal hemangioblastoma (RH) is the most frequent and the earliest clinical sign of the disease, which is seen in 40.0-60.0% of patients. In recent years, studies of patients with VHL tried to put forward the relationship between genotype and phenotype. In this study, two VHL cases in the same family with clinical findings and genetic analysis results are presented. As a consequence of the genetic studies, a heterozygous missense mutation c.202 T>C, p.S68P (Ser68Pro) in exon 1 of the gene that is mapped to chromosome 3p25.3, was found in the patients' DNA sample. The germline mutation of [c.202T>C, p.S68P (Ser68Pro)] that was detected in both cases, has been reported in only two cases in the literature. However, in these reported cases, any systemic involvement except RH, were not reported. Although our cases had the same mutation, we detected renal involve-ment in both cases, and also central nervous system (CNS) involvement in one case, in addition to RH.

References

Wong W, Agron E, Coleman H, Reed G, Csaky K, Peterson J . Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis. Arch Ophthalmol. 2007; 125(2):239-45. PMC: 3019103. DOI: 10.1001/archopht.125.2.239. View

Welch R . Fluorescein angiography in sickle-cell retinopathy and von Hippel-Lindau disease. Int Ophthalmol Clin. 1977; 17(2):137-54. DOI: 10.1097/00004397-197701720-00012. View

Maher E, Yates J, Harries R, Benjamin C, Harris R, Moore A . Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990; 77(283):1151-63. DOI: 10.1093/qjmed/77.2.1151. View

Hes F, van der Luijt R, Janssen A, Zewald R, de Jong G, Lenders J . Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification. Clin Genet. 2007; 72(2):122-9. DOI: 10.1111/j.1399-0004.2007.00827.x. View

Chew E . Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans Am Ophthalmol Soc. 2006; 103:495-511. PMC: 1447586. View

Singh A, Shields C, Shields J . von Hippel-Lindau disease. Surv Ophthalmol. 2001; 46(2):117-42. DOI: 10.1016/s0039-6257(01)00245-4. View

Sato A, Fukui E, Ohta K . Retinoschisis detected by spectral-domain optical coherence tomography in von hippel-lindau disease. Retin Cases Brief Rep. 2014; 6(3):317-9. DOI: 10.1097/ICB.0b013e3182378c08. View

Latif F, Tory K, Gnarra J, Yao M, Duh F, Orcutt M . Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260(5112):1317-20. DOI: 10.1126/science.8493574. View

Kreusel K, Bechrakis N, Krause L, Neumann H, Foerster M . Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study. Ophthalmology. 2006; 113(8):1418-24. DOI: 10.1016/j.ophtha.2006.02.059. View

10.

Harbour J . Tumor suppressor genes in ophthalmology. Surv Ophthalmol. 1999; 44(3):235-46. DOI: 10.1016/s0039-6257(99)00102-2. View

11.

WOODWARD E, Buchberger A, Clifford S, Hurst L, Affara N, Maher E . Comparative sequence analysis of the VHL tumor suppressor gene. Genomics. 2000; 65(3):253-65. DOI: 10.1006/geno.2000.6144. View